<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1987 (3) TMI 519 - Supreme Court</title>
    <link>https://www.taxtmi.com/caselaws?id=191717</link>
    <description>In a public interest petition on harmful and irrational medicines, the Court declined to order a blanket ban because technical issues of therapeutic value, safety, pricing, manufacture, and enforcement were for the executive to decide on expert advice. It recognised the State&#039;s constitutional duty to protect public health and eliminate injurious drugs, and held that detailed drug policy should not be made by the Court on a writ record. The Court nevertheless issued broad directions for stronger enforcement, central coordination, regional laboratories, proper representation on statutory boards, and prompt consideration of objections to specific medicines by the competent expert body.</description>
    <language>en-us</language>
    <pubDate>Tue, 03 Mar 1987 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 25 Apr 2017 12:20:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=465898" rel="self" type="application/rss+xml"/>
    <item>
      <title>1987 (3) TMI 519 - Supreme Court</title>
      <link>https://www.taxtmi.com/caselaws?id=191717</link>
      <description>In a public interest petition on harmful and irrational medicines, the Court declined to order a blanket ban because technical issues of therapeutic value, safety, pricing, manufacture, and enforcement were for the executive to decide on expert advice. It recognised the State&#039;s constitutional duty to protect public health and eliminate injurious drugs, and held that detailed drug policy should not be made by the Court on a writ record. The Court nevertheless issued broad directions for stronger enforcement, central coordination, regional laboratories, proper representation on statutory boards, and prompt consideration of objections to specific medicines by the competent expert body.</description>
      <category>Case-Laws</category>
      <law>Indian Laws</law>
      <pubDate>Tue, 03 Mar 1987 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=191717</guid>
    </item>
  </channel>
</rss>